Expert led session designed to help life sciences professionals navigate the evolving expectations for packaging and delivery system evaluation under […]
Peter Abbink, PhD, a Pace® Life Sciences expert, will serve as roundtable facilitator for the “Strategies for Targeted Drug Delivery”
Pace® leadership explores inspection-ready quality systems and quality oversight in outsourced environments MINNEAPOLIS, MN – April 8, 2026 Pace® Life
Expanded microbial limits testing lab in Lebanon, NJ boosts capacity and strengthens analytical services MINNEAPOLIS, MN – April 2, 2026
Toxicologist and Pace® Regulatory Expert Sherry Sachdeva to discuss industry updates & impacts MINNEAPOLIS, MN – March 10, 2026 The European Union has expanded how
Senior Expert, Dr. Julie Barnhill, to share practical strategies for ensuring GxP compliance in virtual and hybrid pharma companies MINNEAPOLIS,
Chief Scientific Officer of Pace® Life Sciences Joins Industry Leaders at Advancing Drug Development Forum (ADDF) to Collaborate on Technologies
Pace® expert to leverage extensive knowledge to provide guidance on risk assessments for pharmaceutical and biopharmaceutical companies MINNEAPOLIS, MN –
Company commitment to quality excellence confirmed during FDA Inspection MINNEAPOLIS, MN – August 21, 2025– Pace® Life Sciences, a U.S.-based contract,
The United States is global powerhouse in pharmaceutical contract development and manufacturing, home to some of the world’s most advanced